US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
NASDAQ
Skye Bioscience Inc (SKYE) 銘柄情報

Skye Bioscience Inc (SKYE)

0.69

-0.0109

(-1.56%)

終了 7月12日 5:00AM

0.7038

0.0138

(2.00%)

取引時間後: 7:14AM

Skye Bioscience Inc (SKYE) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.7038

( 0.41% )

買値

0.6703

売値

0.6898

出来高

184,958

平均取引量 (3 か月)

US$ 182,125

財務取引量

US$ 128,642

0.6721 日の範囲 0.71

0.5655 52 週間の範囲 4.9902

時価総額

企業価値

7.821M

前日終値

0.7009

始値

0.70

時刻

最終取引時間

VWAP

0.69552

歳入

-

純利益

-57.33M

発行済株式数

35,143,722

浮動株比率 (%)

65.36%

機関投資家保有比率 (%)

45.24%

配当利回り

PER

-0.48

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-1.45

ベータ

2.94

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating ant... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California. 詳細を表示

セクター

Health Care

業界

-

ウェブサイト

skyebioscience.com

本社

San Diego, United States

設立

-

Skye Bioscience Inc is listed in the Health Care sector of the ナスダック市場 with ticker SKYE. The last closing price for Skye Bioscience was US$0.70. Over the last year, Skye Bioscience shares have traded in a share price range of US$ 0.5655 to US$ 4.9902.

Skye Bioscience currently has 35,143,722 shares in issue. The market capitalisation of Skye Bioscience is US$24.73 million. Skye Bioscience has a price to earnings ratio (PE ratio) of -0.48.

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form PRE 14A - Other preliminary proxy statements

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0038	0.542857142857	0.7	0.7193	0.69	51532	0.70319881	CS
4	-0.1086	-13.3677991137	0.8124	0.8154	0.67	112422	0.70504196	CS
12	-0.0471	-6.27247303236	0.7509	1.12	0.67	173739	0.81180039	CS
26	-0.3062	-30.3168316832	1.01	1.12	0.5655	361286	0.79761986	CS
52	-3.4962	-83.2428571429	4.2	4.9902	0.5655	490097	1.66883318	CS
156	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS
260	-12.7962	-94.7866666667	13.5	17.6473	0.5655	459211	2.65838651	CS

SKYE - Frequently Asked Questions (FAQ)

What is the current Skye Bioscience Inc share price?

The current share price of Skye Bioscience Inc is US$ 0.7038

How many Skye Bioscience Inc shares are in issue?

Skye Bioscience Inc has 35,143,722 shares in issue

What is the market cap of Skye Bioscience Inc?

The market capitalisation of Skye Bioscience Inc is USD 24.73M

What is the 1 year trading range for Skye Bioscience Inc share price?

Skye Bioscience Inc has traded in the range of US$ 0.5655 to US$ 4.9902 during the past year

What is the PE ratio of Skye Bioscience Inc?

The price to earnings ratio of Skye Bioscience Inc is -0.48

What is the registered address of Skye Bioscience Inc?

The registered address for Skye Bioscience Inc is 11250 El Camino Real, San Diego, California, 92130

What is the Skye Bioscience Inc website address?

The website address for Skye Bioscience Inc is skyebioscience.com

sometimes_right

sometimes_right 7分前

YOU directed your "Feds learned from 2008" financial crisis comment, when I offered evidence that 300 banks are in jeopardy of failing... So I naturally thought you were an expert on the 2008 financial crisis with special insight into the workings of FDIC Receiverships - your chosen alias is fdicr,

FrostyIsland3

FrostyIsland3 9分前

Krisgo, Linda Powers and NWBO have violated U.S. securities laws by failing to disclose the existence of a CHM Letter if Baxers is correct because a tentative rejection of DCVax-L by UK regulators would clearly be material information requiring disclosure to the investing public. I agree with Baxer

NotTheRealBeeny

NotTheRealBeeny 11分前

Wouldn't it be perfect if Applbaum drafted the NDAs?
🤣

FrostyIsland3

FrostyIsland3 13分前

Baxer, I gather that you are saying that the CHM issued a CHM Letter to NWBO regarding DCVax-L shortly after the November 2025 CHM meeting and NWBO is going through the procedures described in Section 2.6 of the MHRA guidance. Why do you think the CHM issued a CHM Letter instead of issuing a 2nd RF

DayofReckoning

DayofReckoning 14分前

$TWOH what’s your point?

DayofReckoning

DayofReckoning 16分前

You have to own $TWOH shares to care .. thanks for the insight
Good luck to ya

gitreal

gitreal 16分前

Nobody will ever see a nickel back out of this scam. Sorry, the money's gone......and there's no platinum (gold, silver, etc ). Never was.

gitreal

gitreal 18分前

Hopefully some of those enablers will be named in the SEC complaint when it comes down. They're complicit in this, responsible for millions in investor losses. Benny will be named for sure.

FrostyIsland3

FrostyIsland3 24分前

FormalMHRAConsultant, Section 2.4 of the MHRA regulatory guidance enables the CHM to do one of 3 actions: 1. recommend approval of a new medicine to MHRA; 2. issue a 2nd RFI if there are still problems that prevent recommendation of approval but the CHM anticipates these problems can be overcome; a

jhdf51

jhdf51 24分前

Everyone has missed to be fair. But yes, using AI in this scenario? Waste of time.

JHD

Major Profits

Major Profits 27分前

"Remains to be seen if divys will actually be issued and if restricted or not. First divy in January and still not issued."
Just a guess, but I think they WILL be issued (at least the NEW ones). Restricted. The question, then, will be will they ever become UNrestricted and tradable? 🤷

OMOLIVES

OMOLIVES 27分前

They are on overtime currently. As they should be. Also, it was a complicated agreement between the officers of both Companies. That being Brian Foote:

https://investorshub.advfn.com/uimage/uploads/2026/7/11/[lyyeScreenshot_from_2026-07-11_22-52-20.png
https://investorshub.a

FrostyIsland3

FrostyIsland3 31分前

Is LC's allegation that management has not invested at least $50,000 of their own money in NWBO shares true?

Tr8dervic

Tr8dervic 32分前

Mega Million numbers for 07/10/2026 are:

02 39 44 46 56 Mega Ball 23

There was no Jackpot Winner

The estimated Jackpot was $604.0 Million ( $266.3 Million cash).

The next drawing is on Tuesday, Jul 14, 2026 with an estimated Jackpot of

nowwhat2

nowwhat2 34分前

Only the experts know ;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177776692

https://investorshub.advfn.com/uimage/uploads/2026/7/11/uvvndgutsi_foundational_future.jpg

Make It Jake

Make It Jake 40分前

Current AIM-CASH weekly values – Large-caps decreased; mid-caps and small-caps increased.

Large- and mega-cap stocks : 60.9%
Much like last week, weeks nearest the current value had below-average returns and win rates in the shorter holding periods trending tow

FrostyIsland3

FrostyIsland3 40分前

Blackpool, NWBO is required to disclose the existence of a CHM Letter to investors because it is clearly material information. However, I think Baxers is right that Linda Powers and NWBO would intentionally not report the existence of a CHM Letter because there is no U.S. securities law case that e

fdicr

blah blah blah ... What are you talking about????? Are you sure you are on the right board. THis is FNMA board. do you have anything to say about FNMA?

j e d

Do you still think MHRA got the new analyses around March? And, about how long do you think they need to look at it before making a decision? Thank you.

Luis Andros

Luis Andros 50分前

10 career posts. All 10 saying the exact same thing. 🤭

oceans11

oceans11 52分前

What’s your take home on that?Or is that your weekly gross?

FrostyIsland3

FrostyIsland3 56分前

Linda Powers and NWBO intentionally did not disclose the existence of a CHM Letter to investors i Baxers is correct. Further, Linda Powers acted very upbeat at the 12/29/2025 shareholders' meeting. This would be calculated deception because the shareholders' meeting would have occurred on the same

lakers17

lakers17 56分前

As always with this company, just like NSAV did and everything has been vague. If anyone thinks that 13 billion is real revenue not crypto they created or valued as revenue, I have a bridge for sale. Slimy reporting and accounting. Not audited. Remains to be seen if divys will actually be issue

NebraskaOTC

NebraskaOTC 60分前

LOL!!!! The $FITY excuses here are so great!! The amount of people pretending they are shocked by the selloff of this SCAM is hilarious.
This is great! This is awesome!! LOL!!!
Noooo, this is a SCAM. The selloff of $FITY was coordinated by the usual suspects. 🧌 MY PRECIO

AngeloFoca

AngeloFoca 1時間前

I changed my mind about a documentary on the trials and tribulations of NWBO's dealings in getting DC-Vax L approved.

No... No... nothing less than a 10 part series will do this saga justice.

We'll call it... "Game of Groans"

.

Skye Bioscience

Arch Biopartners

PT Gudang Garam (PK)

Foraco International Mar... (PK)

Betashares Australian Go... (GM)

Pacific Basin Shipping (PK)

State Street SPDR Dow Jo...

First Trust RiverFront D...

Northern Dynasty Minerals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。